<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Concern/Hepatitis.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:31:16 GMT -->
<head>
<meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1">
<meta name="Language" content="es">
<meta name="ContentID" content="1027000">
<meta name="Category" content="Concern">
<meta name="Article" content="Hepatitis">
<title>Hepatitis-Referencias</title>
<link type="text/css" rel="stylesheet" href="../Styles/hnqrHtml.css">
<base target="_self">
</head>
<body>
<div id="Article-Title" class="Article-Title"><a name="Article-Title"></a> 

<p class="Article-Title">Hepatitis</p>
</div>

<div id="Reference-List" class="Reference-List">
<p class="Reference-Autofill"><a href="Hepatitis.htm">Volver al
art&#237;culo.</a></p>

<h3>Referencias para el art&#237;culo</h3>

<ol class="Reference-List">
<li class="Ref">Di Bisceglie AM, Bonkovsky HL, Chopra S, et al. Iron reduction as an adjuvant
to interferon therapy in patients with chronic hepatitis C who have previously not responded
to interferon: a multicenter, prospective, randomized, controlled trial. <em>Hepatology</em>
2000;32:135&#8211;8.</li>

<li class="Ref">Blum AL, Doelle W, Kortum K, et al. Treatment of acute viral hepatitis with
(+)-cyanidanol-3. <em>Lancet</em> 1977;2:1153&#8211;5.</li>

<li class="Ref">Suzuki H, Yamamoto S, Hirayama C, et al. Cianidanol therapy for
HBs-antigen-positive chronic hepatitis: a multicentre, double-blind study. <em>Liver</em>
1986;6:35&#8211;44.</li>

<li class="Ref">Bar-Meir S, Halpern Z, Gutman M, et al. Effect of (+)-cyanidanol-3 on chronic
active hepatitis: A double blind controlled trial. <em>Gut</em> 1985;26:975&#8211;9.</li>

<li class="Ref">Conn HO. Cyanidanol: will a hepatotrophic drug from Europe go west? <em>
Hepatology</em> 1983;3:121&#8211;3.</li>

<li class="Ref">Skotnicki AB. Therapeutic application of calf thymus extract (TFX). <em>Med
Oncol Tumor Pharmacother</em> 1989;6:31&#8211;43 [review].</li>

<li class="Ref">Galli M, Crocchiolo P, Negri C, et al. Attempt to treat acute type B hepatitis
with an orally administered thymic extract (thymomodulin): Preliminary results. <em>Drugs Exp
Clin Res</em> 1985;11:665&#8211;9.</li>

<li class="Ref">Bortolotti F, Cadrobbi P, Crivellaro C, et al. Effect of an orally
administered thymic derivative, thymomodulin, in chronic type B hepatitis in children. <em>
Curr Ther Res</em> 1988;43:67&#8211;72.</li>

<li class="Ref">Civeira MP, Castilla A, Morte S, et al. A pilot study of thymus extract in
chronic non-A, non-B hepatitis. <em>Aliment Pharmacol Ther</em> 1989;3:395&#8211;401.</li>

<li class="Ref">Frezza M, Centini G, Cammareri G, et al. S-adenosylmethionine for the
treatment of intrahepatic cholestasis of pregnancy. Results of a controlled clinical trial.
<em>Hepatogastroenterology</em> 1990;37 Suppl 2:122&#8211;5.</li>

<li class="Ref">Frezza M, Surrenti C, Manzillo G, et al. Oral S-adenosylmethionine in the
symptomatic treatment of intrahepatic cholestasis. A double-blind, placebo-controlled study.
<em>Gastroenterology</em> 1990;99:211&#8211;5.</li>

<li class="Ref">Jenkins PJ, Portmann BP, Eddleston AL, Williams R. Use of polyunsaturated
phosphatidylcholine in HBsAg negative chronic active hepatitis: Results of prospective
double-blind controlled trial. <em>Liver</em> 1982;2:77&#8211;81.</li>

<li class="Ref">Von Herbay A, Stahl W, Niederau C, et al. Diminished plasma levels of vitamin
E in patients with severe viral hepatitis. <em>Free Radic Res</em> 1996;25:461&#8211;6.</li>

<li class="Ref">Pan WH, Wang CY, Huang SM, et al. Vitamin A, vitamin E or beta-carotene status
and hepatitis B-related hepatocellular carcinoma. <em>Ann Epidemiol</em>
1993;3:217&#8211;24.</li>

<li class="Ref">Mezes M, Par A, Nemeth P, Javor T. Studies of the blood lipid peroxide status
and vitamin E levels in patients with chronic active hepatitis and alcoholic liver disease.
<em>Int J Clin Pharmacol Res</em> 1986;6:333&#8211;8.</li>

<li class="Ref">Andreone P, Gramonzi A, Bernardi M. Vitamin E for chronic hepatitis B. <em>Ann
Intern Med</em> 1998;128:156&#8211;7.</li>

<li class="Ref">Houglum K, Venkataramani A, Lyche K, Chojkier M. A pilot study of the effects
of d-alpha-tocopherol on hepatic stellate cell activation in chronic hepatitis C. <em>
Gastroenterology</em> 1997;113:1069&#8211;73.</li>

<li class="Ref">Look MP, Gerard A, Rao GS, et al. Interferon/antioxidant combination therapy
for chronic hepatitis C&#8212;a controlled pilot trial. <em>Antiviral Res</em>
1999;43:113&#8211;22.</li>

<li class="Ref">Yurdakok M, Kanra G. Vitamin E therapy in viral hepatitis. <em>Mikrobiyol
Bul</em> 1986;20:91&#8211;4 [in Turkish].</li>

<li class="Ref">Morishige F, Murata A. Vitamin C for prophylaxis of viral hepatitis B in
transfused patients. <em>J Int Acad Prev Med</em> 1978;5(1):54&#8211;8.</li>

<li class="Ref">Knodell RG, Tate MA, Akl BF, Wilson JW. Vitamin C prophylaxis for post
transfusion hepatitis: lack of effect in a controlled trial. <em>Am J Clin Nutr</em>
1981;34:20&#8211;3.</li>

<li class="Ref">Baur H, Staub H. Treatment of hepatitis with infusions of ascorbic acid:
comparison with other therapies. <em>JAMA</em> 1954;156:565 [abstract].</li>

<li class="Ref">Berkson BM. A conservative triple antioxidant approach to the treatment of
hepatitis C. Combination of Alpha lipoic acid (thioctic acid), silymarin, and selenium: three
case histories. <em>Med Klin</em> 1999;94 Suppl 3:84&#8211;9.</li>

<li class="Ref">Campbell RE, Pruitt FW. Vitamin B12 in the treatment of viral hepatitis. <em>
Am J Med Sci</em> 1952;224:252&#8211;62.</li>

<li class="Ref">Campbell RE, Pruitt FW. The effect of vitamin B12 and folic acid in the
treatment of viral hepatitis. <em>Am J Med Sci</em> 1955;229:8&#8211;15.</li>

<li class="Ref">Wallace AE, Weeks WB. Thiamine treatment of chronic hepatitis B infection.
<em>Am J Gastroenterol</em> 2001;96:864&#8211;8.</li>

<li class="Ref">Abdelmalek MF, Angulo P, Jorgensen RA, et al. Betaine, a promising new agent
for patients with nonalcoholic steatohepatitis: results of a pilot study. <em>Am J
Gastroenterol</em> 2001;96:2711&#8211;17.</li>

<li class="Ref">Takagi H, Nagamine T, Abe T, et al. Zinc supplementation enhances the response
to interferon therapy in patients with chronic hepatitis C. <em>J Viral Hepat</em>
2001;8:367&#8211;71.</li>

<li class="Ref">Watanabe A, Okada K, Shimizu Y, et al. Nutritional therapy of chronic
hepatitis by whey protein (non-heated). J Med 2000;31:283&#8211;302.</li>

<li class="Ref">Magliulo E, Gagliardi B, Fiori GP. Results of a double blind study on the
effect of silymarin in the treatment of acute viral hepatitis carried out at two medical
centres. <em>Med Klin</em> 1978;73:1060&#8211;5 [in German].</li>

<li class="Ref">Bode JC, Schmidt U, Durr HK. Silymarin for the treatment of acute viral
hepatitis? Report of a controlled trial. <em>Med Klin</em> 1977;72:513&#8211;8 [in
German].</li>

<li class="Ref">Vailati A, Aristia L, Sozze E, et al. Randomized open study of the dose-affect
relationship of a short course of IdB 1016 in patients with viral or alcoholic hepatitis. <em>
Fitoterapia</em> 1993;64:219&#8211;27.</li>

<li class="Ref">Buzzelli G, Moscarella S, Giusti A, et al. A pilot study on the liver
protective effect of silybinphosphatidylcholine complex (IdB 1016) in chronic active
hepatitis. <em>Int J Clin Pharmacol Ther Toxicol</em> 1993;31:456&#8211;60.</li>

<li class="Ref">Lirussi F, Okolicsanyi L. Cytoprotection in the nineties: experience with
ursodeoxycholic acid and silymarin in chronic liver disease. <em>Acta Physiol Hung</em>
1992;80:363&#8211;7.</li>

<li class="Ref">Schuppan D, Str&#246;sser W, Burkard G, Walosek G. Legalon&#174; lessens
fibrosing activity in patients with chronic liver diseases. <em>Zeits Allgemeinmed</em>
1998;74:577&#8211;84.</li>

<li class="Ref">Thyagarajan SP, Subramian S, Thirunalasundari T, et al. Effects of Phyllanthus
amarus on chronic carriers of hepatitis B virus. <em>Lancet</em> 1988;2:764&#8211;6.</li>

<li class="Ref">Doshi JC, Vaidya AB, Antarkar DS, et al. A two-stage clinical trial of
Phyllanthus amarus in hepatitis B carriers: Failure to eradicate the surface antigen. <em>
Indian J Gastroenterol</em> 1994;13:7&#8211;8.</li>

<li class="Ref">Leelarasamee A, Trakulsomboon S, Maunwongyathi P, et al. Failure of
Phyllanthus amarus to eradicate hepatitis B surface antigen from symptomless carriers. <em>
Lancet</em> 1990;335:1600&#8211;1.</li>

<li class="Ref">Wang M, Cheng H, Li Y, et al. Herbs of the genus Phyllanthus in the treatment
of chronic hepatitis B: observations with three preparations from different geographical
sites. <em>J Lab Clin Med</em> 1995;126:350&#8211;2.</li>

<li class="Ref">Yang DG. Comparison of pre- and post-treatmental hepatohistology with heavy
dosage of Paeonia rubra on chronic active hepatitis caused liver fibrosis. <em>Chung Kuo Chung
Hsi I Chieh Ho Tsa Chih</em> 1994;14:195,207&#8211;9 [in Chinese].</li>

<li class="Ref">Wang CB, Chang AM. Plasma thromboxane B2 changes in severe icteric hepatitis
treated by traditional Chinese medicine&#8212;dispelling the pathogenic heat from blood,
promoting blood circulation and administrating large doses of radix Paeoniae&#8212;a report of
6 cases. <em>Chung Hsi I Chieh Ho Tsa Chih</em> 1985;5:322,326&#8211;8 [in Chinese].</li>

<li class="Ref">Hirayama C, Okumura M, Tanikawa K, et al. A multicenter randomized controlled
clinical trial of Shosaiko-to in chronic active hepatitis. <em>Gastroent Jap</em>
1989;24:715&#8211;9.</li>

<li class="Ref">Fujiwara K, Ohta Y, Ogata I, et al. Treatment trial of traditional Oriental
medicine in chronic viral hepatitis. In: Ohta Y (ed) <em>New Trends in Peptic Ulcer and
Chronic Hepatitis: Part II. Chronic Hepatitis</em>. Tokyo: Excerpta Medica, 1987,
141&#8211;6.</li>

<li class="Ref">Tajiri H, Kozaiwa K, Osaki Y, et al. The study of the effect of sho-saiko-to
on HBeAg clearance in children with chronic HBV infection and with abnormal liver function
tests. <em>Acta Paediatr Jpn</em> 1991;94:1811&#8211;5.</li>

<li class="Ref">Gibo Y, Nakamura Y, Takahashi N, et al. Clinical study of sho-saiko-to therapy
for Japanese patients with chronic hepatitis C (CH-C). <em>Prog Med</em>
1994;14:217&#8211;9.</li>

<li class="Ref">Gibo Y, Nakamura Y, Takahashi N, et al. Clinical study of sho-saiko-to therapy
for Japanese patients with chronic hepatitis C (CH-C). <em>Prog Med</em>
1994;14:217&#8211;9.</li>

<li class="Ref">Oka H, Yamamoto S, Kuroki T, et al. Prospective study of chemoprevention of
hepatocellular carcinoma with sho-saiko-to (TJ-9). <em>Cancer</em> 1995;76:743&#8211;9.</li>

<li class="Ref">Mizushima Y, Oosaki R, Kobayashi M. Clinical features of pneumonitis induced
by herbal drugs. <em>Phytother Res</em> 1997;11:295&#8211;8.</li>

<li class="Ref">Suzuki H, Ohta Y, Takino T, et al. Effects of glycyrrhizin on biochemical
tests in patients with chronic hepatitis. Double blind trial. <em>Asian Med J</em>
1983;26:423&#8211;38.</li>

<li class="Ref">Yasuda K, Hino K, Fujioka S, et al. Effects of high dose therapy with Stronger
Neo-Minophagen C (SNMC) on hepatic histography in non-A, non-B chronic active hepatitis. In
<em>Viral Hepatitis C, D, E,</em> ed. T Shikata, RH Purcell, T Uchida. Amsterdam: Excerpta
Medica, 1991, 205&#8211;9.</li>

<li class="Ref">Crance JM, L&#8217;eveque F, Biziagos E, et al. Studies on mechanism of action
on glycyrrhizin against hepatitis A virus replication in vitro. <em>Antiviral Res</em>
1994;23:63&#8211;76.</li>

<li class="Ref">Su XS, Chen HM, Wang LH, et al. Clinical and laboratory observation on the
effect of glycyrrhizin in acute and chronic viral hepatitis. <em>J Trad Chin Med</em>
1984;4:127&#8211;32.</li>

<li class="Ref">Chaturvedi GN, Singh RH. Jaundice of infectious hepatitis and its treatment
with an indigenous drug, <em>Picrorhiza kurrooa</em> [sic]. <em>J Res Ind Med</em>
1966;1:1&#8211;13.</li>

<li class="Ref">Chaturvedi GN, Tomar GS, Tiwari SK, Singh KP. Clinical studies on kalmegh
(<em>Andrographis paniculata</em>) in infective hepatitis. <em>J Int Inst Ayurveda</em>
1983;2:208&#8211;11.</li>

<li class="Ref">Hobbs, C. <em>Medicinal Mushrooms</em>. Santa Cruz, CA: Botanica Press, 1995,
96&#8211;107.</li>

<li class="Ref">Harada T, Kanetaka T, Suzuki H, Suzuki K. Therapeutic effect of LEM (extract
of cultured <em>Lentinus edodes</em> mycelia) against HBeAg-positive chronic hepatitis B. <em>
Gastroenterol Int</em> 1988;1(suppl 1):abstract 719.</li>

<li class="Ref">Liu KT. Studies on <em>fructus Schisandrae chinensis</em>. Annex 12: Studies
on <em>fructus Schisandrae chinensis</em>. Plenary lecture, World Health Organization Seminar
on the Use of Medicinal Plants in Health Care, Sept 1977, Tokyo, Japan. In: WHO Regional
Office for the Western Pacific Final Report, Manila, 1977, 101&#8211;12.</li>

<li class="Ref">Chang HM, But P (eds). <em>Pharmacology and Applications of Chinese Materia
Medica</em> vol 1. Singapore: World Scientific, 1986.</li>

<li class="Ref">Tang W, Eisenbrand G. <em>Chinese Drugs of Plant Origin</em>. Berlin: Springer
Verlag, 1992.</li>

<li class="Ref">Bone K, Morgan M. <em>Clinical Applications of Ayurvedic and Chinese Herbs:
Monographs for the Western Herbal Practitioner.</em> Warwick, Australia: 1996.</li>
</ol>
</div>
</body>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Concern/Hepatitis.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:31:16 GMT -->
</html>

